Study | Instrument | Pre-TMS**** | Post-TMS | Remission | Response | Side effects (mother) | Infants |
---|---|---|---|---|---|---|---|
D. R. Kim et al., 2019 [58] | HDRS-17 | 23.18 ± 3.54 | 9.27 ± 6.05 | 3 | 9 | 1 (10%) | 4 (36%) |
22.27 ± 2.65 | 13.18 ± 8.00 | 2 | 5 | ||||
Myczkowski et al., 2012 [59] | HDRS-17 | 29.13 ± 5.64 | 18.50 ± 9.83 | * | * | 2 (25%) | 0 (0%) |
26.67 ± 5.68 | 24.83 ± 7.60 | ||||||
D. R. Kim et al., 2011 [60] | HDRS-17 | 24.4 ± 5.6 | 9.7 ± 6.1 | 3 | 7 | 4 (40%) | 0 (0%) |
Hizli Sayar et al., 2014 [61] | HDRS-17 | 26.67 ± 5.58 | 13.03 ± 6.93 | 6 | 12 | 0 (0%) | 0 (0%) |
Garcia et al., 2010 [62] | HDRS-24 | 22.67 ± 6.44 | 2.14 ± 3.19 | 8 | 9 | 2 (29%) | 0 (0%) |
Zhang et al., 2010 [63] | HDRS-24 | 35 | 8 | 1 | 1 | 0 (0%) | 0 (0%) |
Tan et al., 2008 [64] | HDRS-17 | 38 | 4 | 1 | 1 | 0 (0%) | 0 (0%) |
Ferra˜o et al., 2018 [65] | HDRS-21 | 24.33 ± 5.24 | 7.33 ± 4.03 | 2 | 3 | 2 (66%) | 1 (25%) |
12 | 6 | 1 | 1 | 1 (100%) | |||
Cohen et al., 2008 [66] | HDRS-17 | 18 | 6 | 1 | 1 | 0 (0%) | 0 (0%) |
Monika KlÃrová et al., 2008 [67] | MADRS | 33 | 2 | * | * | 0 (0%) | 0 (0%) |
BDI | 29 | 12 | * | * |